This segment focuses on developing non-antibiotic solutions for preventing and treating diseases in poultry and other livestock. Research and development efforts are centered on identifying and isolating bioactive molecules from ZIVO's proprietary algal cultures that exhibit immune-modulating and anti-inflammatory properties. These compounds are being formulated into feed additives and supplements to improve animal health, reduce reliance on antibiotics, and enhance overall productivity. The segment addresses critical issues such as coccidiosis and avian influenza, aiming to provide sustainable and effective alternatives to traditional treatments. ZIVO collaborates with leading animal health companies and universities to validate the efficacy and safety of its products through rigorous clinical trials and field studies. The ultimate goal is to create a new class of therapeutic products that promote animal well-being and contribute to a more sustainable and responsible food production system.

This segment is dedicated to exploring the potential of ZIVO's algal-derived compounds for human health applications, focusing on nutritional supplements and medical foods. Research efforts are directed towards identifying bioactive molecules with therapeutic benefits, such as immune support, cholesterol management, and anti-inflammatory effects. The company is investigating the use of its proprietary algal strains to produce novel ingredients for dietary supplements and functional foods. This includes exploring potential applications in areas such as gut health, metabolic disorders, and age-related diseases. ZIVO aims to develop products that address unmet needs in human health and wellness, leveraging its expertise in algal biotechnology and bioactive molecule discovery. The segment also focuses on securing patents and regulatory approvals to protect its intellectual property and ensure the safety and efficacy of its products. Future opportunities include expanding into personalized nutrition and developing targeted therapies based on individual health profiles.